Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Geriatrics ; 41(11): 51-6, 59-60, 64, 1986 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-3770483

RESUMO

Tight glycemic control in the elderly diabetic patient can drastically alter the patient's life-style. A balanced approach allows somewhat higher plasma glucose levels while preventing the serious acute complications of poor glycemic control. Sulfonylureas are the agents of choice in most elderly type II diabetic patients when fasting plasma glucose cannot be maintained below 140 mg/dl with diet and exercise. Consider insulin therapy when symptomatic fasting hyperglycemia above 200 mg/dl persists.


Assuntos
Diabetes Mellitus Tipo 2/tratamento farmacológico , Compostos de Sulfonilureia/uso terapêutico , Idoso , Diabetes Mellitus Tipo 2/diagnóstico , Diabetes Mellitus Tipo 2/metabolismo , Teste de Tolerância a Glucose , Humanos , Compostos de Sulfonilureia/administração & dosagem , Compostos de Sulfonilureia/efeitos adversos
2.
Ann Emerg Med ; 13(4): 234-6, 1984 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-6703428

RESUMO

Among 218 patients treated for prehospital arrest during an eight-month baseline period prior to addition of bretylium tosylate to the paramedic protocol in Columbus, 16 (7.3%) were seen with refractory ventricular fibrillation (RVF). These patients failed to respond to multiple countershocks, lidocaine, bicarbonate and epinephrine, and either were transported in arrest during cardiopulmonary resuscitation (CPR)(14) or were pronounced dead at the scene (2). A single patient was eventually resuscitated in and discharged from the hospital. During the subsequent 16 1/2-month experience with bretylium used only for prehospital RVF, 421 patients with prehospital arrest were seen, 35 of whom (8.3%) had RVF. All but five patients were defibrillated successfully, and 14 (40%) were converted to a rhythm sufficient to obviate CPR during transportation. Eleven patients (31%) survived to be admitted to the hospital, and eight of 35 (23% vs 1/16 or 6.2% above, P less than .05) were discharged and remained well three to 17 months later. Bretylium tosylate may provide life-saving therapy for refractory prehospital ventricular fibrillation so that survival from an almost uniformly fatal condition is improved. While patients with persistent arrest generally should be transported to the hospital, such patients should not be subjected to the difficulties of CPR in transit unless they are first given bretylium if RVF is present.


Assuntos
Compostos de Bretílio/uso terapêutico , Tosilato de Bretílio/uso terapêutico , Serviços Médicos de Emergência , Fibrilação Ventricular/tratamento farmacológico , Feminino , Parada Cardíaca/terapia , Humanos , Masculino , Pessoa de Meia-Idade , Prognóstico , Ressuscitação , Transporte de Pacientes
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA